Sep 20, 2023

Accelerating Drug Target Identification and Validation with AI and Digital Twins: Join our CBO, Joseph Donahue at BioTechX Europe 2023

We are thrilled to announce that Aitia will be participating in Basel at the BioTechX Europe 2023 conference. Our CBO, Joseph Donahue, will be taking the stage in the AI in Drug Development and Discovery session to talk about Aitia’s commitment in accelerating AI-driven discoveries and share valuable insights on harnessing Causal AI and Digital Twins to revolutionize drug discovery and development.

In this session, Joseph will delve into an in-depth discussion of the latest developments in AI pertaining to target identification, drug development, and clinical trials. This session will also explore the significant expansion of data in the realm of AI and the new frontiers associated with applying AI in the field of drug development.

We invite you to join us at the BioTechX Europe 2023 conference on October 5th at 12:05PM, and be a part of this scientific session. More information on the BioTechX Europe 2023 conference here.